Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma.

Authors: Karp, CL  Grupe, A  Schadt, E  Ewart, SL  Keane-Moore, M  Cuomo, PJ  Kohl, J  Wahl, L  Kuperman, D  Germer, S  Aud, D  Peltz, G  Wills-Karp, M 
Citation: Karp CL, etal., Nat Immunol. 2000 Sep;1(3):221-6.
Pubmed: (View Article at PubMed) PMID:10973279
DOI: Full-text: DOI:10.1038/79759

The prevalence and severity of allergic asthma continue to rise, lending urgency to the search for environmental triggers and genetic substrates. Using microarray analysis of pulmonary gene expression and single nucleotide polymorphism-based genotyping, combined with quantitative trait locus analysis, we identified the gene encoding complement factor 5 (C5) as a susceptibility locus for allergen-induced airway hyperresponsiveness in a murine model of asthma. A deletion in the coding sequence of C5 leads to C5-deficiency and susceptibility. Interleukin 12 (IL-12) is able to prevent or reverse experimental allergic asthma. Blockade of the C5a receptor rendered human monocytes unable to produce IL-12, mimicking blunted IL-12 production by macrophages from C5-deficient mice and providing a mechanism for the regulation of susceptibility to asthma by C5. The role of complement in modulating susceptibility to asthma highlights the importance of immunoregulatory events at the interface of innate and adaptive immunity in disease pathogenesis.


Disease Annotations
Objects Annotated

Additional Information

CRRD Object Information
CRRD ID: 5130158
Created: 2011-04-06
Species: All species
Last Modified: 2011-04-06
Status: ACTIVE


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.